128 related articles for article (PubMed ID: 11900184)
1. Autologous bone marrow transplants.
Rose LJ
Health Aff (Millwood); 2002; 21(2):308. PubMed ID: 11900184
[No Abstract] [Full Text] [Related]
2. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
Cunningham R
Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
[No Abstract] [Full Text] [Related]
3. ABMT and breast cancer.
Firshein J
Healthplan; 1999; 40(4):30-3, 35-7. PubMed ID: 10557735
[No Abstract] [Full Text] [Related]
4. Efficacy of autologous bone marrow transplants as treatment for breast cancer.
Uzych L
J Am Med Womens Assoc (1972); 1992; 47(1):3. PubMed ID: 1545106
[No Abstract] [Full Text] [Related]
5. Health insurance: coverage of autologous bone marrow transplantation for breast cancer.
Jaggar SF
Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925
[No Abstract] [Full Text] [Related]
6. Health insurance coverage for emerging medical technologies: a new approach.
Puzio D
Tort Trial Insur Pract Law J; 2003; 38(4):1019-47. PubMed ID: 14503539
[No Abstract] [Full Text] [Related]
7. BCBS must pay autologous bone marrow transplants.
Margolis RE
Healthspan; 1991 Apr; 8(4):22-3. PubMed ID: 10183479
[No Abstract] [Full Text] [Related]
8. Tide turning against autologous bone marrow transplants in federal appellate courts.
Margolis RE
Healthspan; 1993 Jun; 10(6):21-2. PubMed ID: 10127304
[No Abstract] [Full Text] [Related]
9. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.
Mello MM; Brennan TA
Health Aff (Millwood); 2001; 20(5):101-17. PubMed ID: 11558695
[TBL] [Abstract][Full Text] [Related]
10. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Krause KJ
N Engl J Med; 1994 Aug; 331(5):329; author reply 330-1. PubMed ID: 8068113
[No Abstract] [Full Text] [Related]
11. Autologous bone marrow transplantation for advanced breast cancer.
Med Lett Drugs Ther; 1991 May; 33(843):39-40. PubMed ID: 2014014
[No Abstract] [Full Text] [Related]
12. Federal courts still split on autologous bone marrow transplants.
Margolis RE
Healthspan; 1992 Dec; 9(11):20-2. PubMed ID: 10123554
[No Abstract] [Full Text] [Related]
13. Experimental medical treatments: who should decide coverage?
Collins JC
Spec Law Dig Health Care Law; 1998 Jan; (226):9-45. PubMed ID: 10176412
[No Abstract] [Full Text] [Related]
14. No place for politics.
Fee K
Mod Healthc; 2000 May; 30(21):48, 50. PubMed ID: 11067549
[No Abstract] [Full Text] [Related]
15. Cancer coverage. Why are insurers paying for this "experimental" therapy?
Med Econ; 1996 Sep; 73(17):38. PubMed ID: 10161873
[No Abstract] [Full Text] [Related]
16. 3rd Circuit keeps split alive on autologous bone marrow transplants for breast cancer. Clark v. K-Mart Corporation.
Margolis RE
Healthspan; 1992; 9(7):21-2. PubMed ID: 10183724
[No Abstract] [Full Text] [Related]
17. ABMT and breast cancer: what have we learned?
Brown E
Physician Exec; 1999; 25(4):86-8. PubMed ID: 10557495
[TBL] [Abstract][Full Text] [Related]
18. The role of bone marrow transplantation in the management of advanced local disease.
Safah H; Weiner RS
Surg Oncol Clin N Am; 1995 Oct; 4(4):735-49. PubMed ID: 8535908
[TBL] [Abstract][Full Text] [Related]
19. Experimental medical treatments: who should decide coverage?
Collins JC
Seattle Univ Law Rev; 1997; 20(2):451-87. PubMed ID: 16528856
[No Abstract] [Full Text] [Related]
20. New approach to administrative medical decision-making: evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer.
Lucey C; Westphal JR
South Med J; 1998 Feb; 91(2):196-201. PubMed ID: 9496875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
